Your browser doesn't support javascript.
loading
Evaluation of three decades of the burden of low back pain in China before COVID-19: Estimates from the Global Burden of Disease Database 2019.
Xu, Shuai; Qi, Jinlei; Liu, Chenjun; Xia, Weiwei; Wang, Zhenbo; Li, Kexin; Zhou, Maigeng; Liu, Haiying.
Afiliación
  • Xu S; Department of Spinal Surgery, Peking University People's Hospital, Peking University, Beijing, China.
  • Qi J; National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Liu C; Department of Spinal Surgery, Peking University People's Hospital, Peking University, Beijing, China.
  • Xia W; Department of Spinal Surgery, Peking University People's Hospital, Peking University, Beijing, China.
  • Wang Z; Institute of Geographical Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing, China.
  • Li K; Institute of Geographical Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing, China.
  • Zhou M; National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Liu H; Department of Spinal Surgery, Peking University People's Hospital, Peking University, Beijing, China.
J Glob Health ; 14: 04006, 2024 Mar 15.
Article en En | MEDLINE | ID: mdl-38487857
ABSTRACT

Background:

Low back pain (LBP) is reported as an urgent public-health concern globally because it occurs in all age groups and is now the leading cause of disability, with health systems unable to cope with this burden. We present China's burden of LBP by estimating its prevalence and years lived with disability (YLDs) from 1990 to 2019.

Methods:

We obtained the data relating to LBP from the Global Burden of Disease Database (GBD) 2019. Then we calculated years lived with disability caused by LBP by multiplying the prevalence of LBP sequelae by their corresponding disability weights. We performed an analysis of the age-, sex-, and province-specific prevalence and YLDs of 33 provinces/regions in China, as well as their relationship with the sociodemographic index (SDI).

Results:

China has the largest numbers of people with LBP (91.3 million) and YLDs (8.6 million) globally, and LBP is the leading cause of YLDs. The age-standardised prevalence was 7.25% in 1990, and this decreased to 5.13% in 2019. The age-standardised YLD rate was 579/100 000 in 2019, having decreased by 28.97%. Both measurements increased with age, being higher in women and varying across the 33 provinces/regions. For the 5-to-14-year age group, the prevalence (4.50%) and YLD rate (4.51%) increased in 2019 from 1990 (3.21% and 3.21%, respectively) when compared to the elderly group. Age-standardised YLD rates experienced decreases with increasing SDI, while there was an increasing tendency as SDI increased further; the changes for women were more obvious.

Conclusions:

Over the three decades considered, China has continued to have the largest number of people with LBP in the world, even though the age-standardised prevalence has decreased. YLDs were found to decrease as SDI increased, but they subsequently increased again. LBP still presents a burden, particularly for children and postmenopausal women.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dolor de la Región Lumbar / COVID-19 Límite: Aged / Child / Female / Humans País/Región como asunto: Asia Idioma: En Revista: J Glob Health Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dolor de la Región Lumbar / COVID-19 Límite: Aged / Child / Female / Humans País/Región como asunto: Asia Idioma: En Revista: J Glob Health Año: 2024 Tipo del documento: Article País de afiliación: China